 |  |
| DBX | ||
| 3,226.607 | ||
| -20.7060 | -0.0064% | |
| ECONOMIC30 | ||
| 110.318 | ||
| -2.0120 | -0.0179% | |
| ESGQKEHATI | ||
| 119.281 | ||
| 0.2400 | 0.0020% | |
| ESGSKEHATI | ||
| 119.064 | ||
| 0.1570 | 0.0013% | |
| I-GRADE | ||
| 209.204 | ||
| -0.7100 | -0.0034% | |
| ABX | ||
| 1,456.150 | ||
| -1.0530 | -0.0007% | |
| BISNIS-27 | ||
| 509.741 | ||
| 0.6770 | 0.0013% | |
| DBX | ||
| 3,226.607 | ||
| -20.7060 | -0.0064% | |
| ECONOMIC30 | ||
| 110.318 | ||
| -2.0120 | -0.0179% | |
| ESGQKEHATI | ||
| 119.281 | ||
| 0.2400 | 0.0020% | |
| ESGSKEHATI | ||
| 119.064 | ||
| 0.1570 | 0.0013% | |
| I-GRADE | ||
| 209.204 | ||
| -0.7100 | -0.0034% | |
| ABX | ||
| 1,456.150 | ||
| -1.0530 | -0.0007% | |
| BISNIS-27 | ||
| 509.741 | ||
| 0.6770 | 0.0013% | |
| DBX | ||
| 3,226.607 | ||
| -20.7060 | -0.0064% | |
| ECONOMIC30 | ||
| 110.318 | ||
| -2.0120 | -0.0179% | |
| ESGQKEHATI | ||
| 119.281 | ||
| 0.2400 | 0.0020% | |
| AUDRP | ||
| 10,632.160 | ||
| -48.1600 | -0.4509% | |
| EURRP | ||
| 18,982.290 | ||
| -142.0000 | -0.7425% | |
| JPYRP | ||
| 111.432 | ||
| -0.5153 | -0.4603% | |
| SINRP | ||
| 12,740.910 | ||
| -54.5600 | -0.4264% | |
| USDRP | ||
| 16,395.000 | ||
| -115.0000 | -0.6965% | |
| AUDRP | ||
| 10,632.160 | ||
| -48.1600 | -0.4509% | |
| EURRP | ||
| 18,982.290 | ||
| -142.0000 | -0.7425% | |
| JPYRP | ||
| 111.432 | ||
| -0.5153 | -0.4603% | |
| SINRP | ||
| 12,740.910 | ||
| -54.5600 | -0.4264% | |
| USDRP | ||
| 16,395.000 | ||
| -115.0000 | -0.6965% | |
| AUDRP | ||
| 10,632.160 | ||
| -48.1600 | -0.4509% | |
| EURRP | ||
| 18,982.290 | ||
| -142.0000 | -0.7425% | |
| JPYRP | ||
| 111.432 | ||
| -0.5153 | -0.4603% | |
| SINRP | ||
| 12,740.910 | ||
| -54.5600 | -0.4264% | |
| USDRP | ||
| 16,395.000 | ||
| -115.0000 | -0.6965% | |
Badan Pengawasan Obat dan Makanan (BPOM) mengeluarkan izin penggunaan darurat (EUA) untuk vaksin COVID-19 Novavax yang diproduksi India dengan merk Covovax. Vaksin ini menjadi alternatif ke-11 untuk penanganan COVID-19 di Indonesia.
